Eplerenone appears cost-effective for people with heart failure after acute myocardial infarction. Commentary 2.
| Autor: | Grauer DW; Department of Pharmacy Practice, University of Kansas, USA. |
|---|---|
| Jazyk: | angličtina |
| Zdroj: | Evidence-based cardiovascular medicine [Evid Based Cardiovasc Med] 2005 Sep; Vol. 9 (3), pp. 225-6, 228-9. Date of Electronic Publication: 2005 Jul 27. |
| DOI: | 10.1016/j.ebcm.2005.06.016 |
| Databáze: | MEDLINE |
| Externí odkaz: |
|
Full Text from ScienceDirect